ArticleEndocrinology, diabetes & metabolism2026

Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A 25-Week Prospective Multicenter Comparative Cohort Study.

Mukulesh Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.